IL209145A0 - Narcotic emulsion formulations for treatment of surgical pain - Google Patents

Narcotic emulsion formulations for treatment of surgical pain

Info

Publication number
IL209145A0
IL209145A0 IL209145A IL20914510A IL209145A0 IL 209145 A0 IL209145 A0 IL 209145A0 IL 209145 A IL209145 A IL 209145A IL 20914510 A IL20914510 A IL 20914510A IL 209145 A0 IL209145 A0 IL 209145A0
Authority
IL
Israel
Prior art keywords
treatment
emulsion formulations
surgical pain
narcotic emulsion
narcotic
Prior art date
Application number
IL209145A
Other languages
English (en)
Original Assignee
Teikoku Pharma Usa Inc
Techno Guard Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc, Techno Guard Co Ltd filed Critical Teikoku Pharma Usa Inc
Publication of IL209145A0 publication Critical patent/IL209145A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL209145A 2008-05-15 2010-11-04 Narcotic emulsion formulations for treatment of surgical pain IL209145A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5357108P 2008-05-15 2008-05-15
US12/424,382 US20090286832A1 (en) 2008-05-15 2009-04-15 Narcotic emulsion formulations for treatment of surgical pain
PCT/US2009/041991 WO2009140059A2 (en) 2008-05-15 2009-04-28 Narcotic emulsion formulations for treatment of surgical pain

Publications (1)

Publication Number Publication Date
IL209145A0 true IL209145A0 (en) 2011-01-31

Family

ID=41316744

Family Applications (1)

Application Number Title Priority Date Filing Date
IL209145A IL209145A0 (en) 2008-05-15 2010-11-04 Narcotic emulsion formulations for treatment of surgical pain

Country Status (16)

Country Link
US (1) US20090286832A1 (cg-RX-API-DMAC7.html)
EP (1) EP2276440A4 (cg-RX-API-DMAC7.html)
JP (2) JP5689053B2 (cg-RX-API-DMAC7.html)
KR (1) KR101361479B1 (cg-RX-API-DMAC7.html)
CN (1) CN101938963A (cg-RX-API-DMAC7.html)
AR (1) AR071779A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009246713B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0907224A2 (cg-RX-API-DMAC7.html)
CA (1) CA2710546A1 (cg-RX-API-DMAC7.html)
EA (1) EA201000991A1 (cg-RX-API-DMAC7.html)
IL (1) IL209145A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010007698A (cg-RX-API-DMAC7.html)
NZ (1) NZ586461A (cg-RX-API-DMAC7.html)
TW (2) TW201406403A (cg-RX-API-DMAC7.html)
WO (1) WO2009140059A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201004392B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090286832A1 (en) * 2008-05-15 2009-11-19 Kiichiro Nabeta Narcotic emulsion formulations for treatment of surgical pain
EP2400838B1 (en) * 2009-02-26 2016-05-11 Teikoku Pharma USA, Inc. Narcotic emulsion formulations for treatment of cancer pain
JP6081240B2 (ja) * 2013-03-13 2017-02-15 テルモ株式会社 レミフェンタニル注射液剤
EP3192509B1 (en) 2014-09-12 2021-03-31 Terumo Kabushiki Kaisha Remifentanil injection
WO2021252449A1 (en) * 2020-06-08 2021-12-16 Harm Reduction Therapeutics, Inc. Sterilized formulations

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
ATE183092T1 (de) * 1995-10-28 1999-08-15 Braun Melsungen Ag Lokalanästhetika und/oder zentralanalgetika enthaltende pharmazeutische zusammensetzungen
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6455525B1 (en) * 1999-11-04 2002-09-24 Cephalon, Inc. Heterocyclic substituted pyrazolones
US7211596B2 (en) * 2001-05-11 2007-05-01 Mitsubishi Pharma Corporation Stable high-concentration injection containing pyrazolone derivative
BRPI0307017B1 (pt) * 2002-01-25 2015-11-10 Theravance Biopharma R & D Ip Llc compostos de éster de ácido fenilacético, composições farmacêuticas e uso de ditos compostos para preparar um medicamento útil para induzir ou manter a anestesia ou sedação
JP2004043479A (ja) * 2002-07-11 2004-02-12 Taiho Yakuhin Kogyo Kk 経鼻吸収用組成物
UA80447C2 (en) * 2002-10-08 2007-09-25 Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
JP4584713B2 (ja) * 2002-10-08 2010-11-24 ライナット ニューロサイエンス コーポレイション 神経成長因子アンタゴニストを投与することによって術後疼痛を処置するための方法および神経成長因子アンタゴニストを含有する組成物
US7648982B2 (en) * 2003-02-28 2010-01-19 Ym Biosciences Inc. Opioid delivery system
JP2004275852A (ja) * 2003-03-14 2004-10-07 Mitsubishi Heavy Ind Ltd 排煙脱硝触媒及びその製造方法
JP2007538091A (ja) * 2004-05-17 2007-12-27 ファーマコフォア・インコーポレイテッド 痛みを処置または予防するための組成物および方法
DE102004025357B4 (de) * 2004-05-19 2007-03-29 Beiersdorf Ag Emulsionskonzentrat mit wasserlöslichen und öllöslichen Polymeren und kosmetische Zubereitung enthaltend Emulsionskonzentrat sowie ein Verfahren zu dessen Herstellung und dessen Verwendung
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US20060189682A1 (en) * 2005-02-02 2006-08-24 Payne Joseph E Water soluble prodrugs of COX-2 inhibitors
US20080128314A1 (en) * 2005-03-14 2008-06-05 Koichi Takeda Pharmaceutical Composition Containing Hardly Water Soluble Medicament
CN101166515A (zh) * 2005-04-22 2008-04-23 美国诺华卡迪亚公司 用于非水溶性药物成分静脉注射的乳剂的生产
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
RU2432950C2 (ru) * 2006-01-25 2011-11-10 Инсис Терапьютикс Инк. Подъязычный спрей на основе фентанила
US20090286832A1 (en) * 2008-05-15 2009-11-19 Kiichiro Nabeta Narcotic emulsion formulations for treatment of surgical pain
EP2400838B1 (en) * 2009-02-26 2016-05-11 Teikoku Pharma USA, Inc. Narcotic emulsion formulations for treatment of cancer pain

Also Published As

Publication number Publication date
WO2009140059A3 (en) 2010-01-07
JP5889364B2 (ja) 2016-03-22
AR071779A1 (es) 2010-07-14
TW201006508A (en) 2010-02-16
BRPI0907224A2 (pt) 2019-02-26
EP2276440A4 (en) 2011-06-29
CA2710546A1 (en) 2009-11-19
CN101938963A (zh) 2011-01-05
AU2009246713A1 (en) 2009-11-19
ZA201004392B (en) 2011-06-29
EP2276440A2 (en) 2011-01-26
US20090286832A1 (en) 2009-11-19
KR101361479B1 (ko) 2014-02-12
MX2010007698A (es) 2010-11-22
JP5689053B2 (ja) 2015-03-25
AU2009246713B2 (en) 2012-10-25
JP2014205681A (ja) 2014-10-30
TWI413531B (zh) 2013-11-01
KR20100126270A (ko) 2010-12-01
EA201000991A1 (ru) 2011-06-30
WO2009140059A2 (en) 2009-11-19
JP2011520883A (ja) 2011-07-21
NZ586461A (en) 2012-07-27
TW201406403A (zh) 2014-02-16

Similar Documents

Publication Publication Date Title
GB0610867D0 (en) Treatment of pain
GB2483419B (en) Formulations for the treatment of deep tissue pain
IL194820A0 (en) Devices and methods for treatment of tissue
IL217777A0 (en) Methods for treatment of pain
PL3064206T3 (pl) Leczenie choroby Huntingtona z zastosowaniem lakwinimodu
IL193748A0 (en) Treatment of pain
ZA201103759B (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
EP2187743A4 (en) FORMULATIONS FOR THE TREATMENT OF DISEASES OR EYE DISORDERS
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
NO2016023I1 (no) Glycerol fenylbutyrat
HRP20181877T1 (hr) Postupci za liječenje lijekovima koji uklanjaju amonijak
IL213703A0 (en) Compounds and methods for the treatment of pain and other diseases
IL209145A0 (en) Narcotic emulsion formulations for treatment of surgical pain
ZA201104963B (en) Narcotic emulsion formulations for treatment of cancer pain
IL215695A (en) Use of Compounds 1-Phenyl-3-Dimethyl Amino Propane for the preparation of rheumatic pain medication
GB0610868D0 (en) Treatment of pain
GB0616450D0 (en) Treatment of pain
EP2432322A4 (en) OPTIMAL COMPOSITIONS AND METHODS OF TREATING ORAL DISEASES AND PAIN
GB0604092D0 (en) Formulation for treatment of paralizing pain stiffness
GB0616122D0 (en) Formulation for treatment of skin disorders
GB0716834D0 (en) New formulation for treatment of skin disorders
GB0720136D0 (en) Treatment of blood disorded
SI2330892T1 (sl) Postopki zdravljenja z uporabo zdravil, ki odstranjujejo amoniak
GB0819543D0 (en) Treatment of proteostatic disease
GB0817859D0 (en) Treatment of proteostatic disease